Hooman Hakami - Net Worth and Insider Trading

Hooman Hakami Net Worth

The estimated net worth of Hooman Hakami is at least $3 Million dollars as of 2024-05-05. Hooman Hakami is the EVP & Group President Diabetes of Medtronic PLC and owns about 30,761 shares of Medtronic PLC (MDT) stock worth over $3 Million. Details can be seen in Hooman Hakami's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Hooman Hakami has not made any transactions after 2019-09-10 and currently still holds the listed stock(s).

Transaction Summary of Hooman Hakami

To

Hooman Hakami Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Hooman Hakami owns 1 companies in total, including Medtronic PLC (MDT) .

Click here to see the complete history of Hooman Hakami’s form 4 insider trades.

Insider Ownership Summary of Hooman Hakami

Ticker Comapny Transaction Date Type of Owner
MDT Medtronic PLC 2019-09-10 EVP & Group President Diabetes

Hooman Hakami Latest Holdings Summary

Hooman Hakami currently owns a total of 1 stock. Hooman Hakami owns 30,761 shares of Medtronic PLC (MDT) as of September 10, 2019, with a value of $3 Million.

Latest Holdings of Hooman Hakami

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MDT Medtronic PLC 2019-09-10 30,761 81.69 2,512,866

Holding Weightings of Hooman Hakami


Hooman Hakami Form 4 Trading Tracker

According to the SEC Form 4 filings, Hooman Hakami has made a total of 2 transactions in Medtronic PLC (MDT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Medtronic PLC is the sale of 82,877 shares on September 10, 2019, which brought Hooman Hakami around $9 Million.

Insider Trading History of Hooman Hakami

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Hooman Hakami Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Hooman Hakami Ownership Network

Ownership Network List of Hooman Hakami

No Data

Ownership Network Relation of Hooman Hakami


Hooman Hakami Owned Company Details

What does Medtronic PLC do?

Who are the key executives at Medtronic PLC?

Hooman Hakami is the EVP & Group President Diabetes of Medtronic PLC. Other key executives at Medtronic PLC include EVP & President & Surgical OU Michael Marinaro , EVP & Group President Diabetes Sean Salmon , and EVP & Group Pres Restora Thera Brett A. Wall .

Medtronic PLC (MDT) Insider Trades Summary

Over the past 18 months, Hooman Hakami made no insider transaction in Medtronic PLC (MDT). Other recent insider transactions involving Medtronic PLC (MDT) include a net sale of 7,997 shares made by Brett A. Wall , a net sale of 47,326 shares made by Sean Salmon , and a net sale of 2,206 shares made by Michael Marinaro .

In summary, during the past 3 months, insiders sold 31,549 shares of Medtronic PLC (MDT) in total and bought 0 shares, with a net sale of 31,549 shares. During the past 18 months, 73,043 shares of Medtronic PLC (MDT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 73,043 shares.

Medtronic PLC (MDT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Medtronic PLC Insider Transactions

No Available Data

Hooman Hakami Mailing Address

Above is the net worth, insider trading, and ownership report for Hooman Hakami. You might contact Hooman Hakami via mailing address: 710 Medtronic Pkwy, Mslc300, Minneapolis Mn 55432.

Discussions on Hooman Hakami

No discussions yet.